Crohn's disease in Caucasians and African Americans, as defined by clinical predictors and single nucleotide polymorphisms

Journal of the National Medical Association

Volumn 104, Issue 9-10, 2012, Pages 420-427

  Kanaan, Ziad ^a   Ahmad, Surriya ^a   Roberts, Henry ^a   Thé, Tama ^a   Girdler, Steven ^a   Pan, Jianmin ^b   Rai, Shesh N ^b   Weller, E Brooks ^a   Galandiuk, Susan ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

African Americans; Gastrointestinal; Genes; Tobacco

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GENOMIC DNA; INTERLEUKIN 23 RECEPTOR;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; CAUCASIAN; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE COURSE; DISEASE PREDISPOSITION; ENTERITIS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IGR GENE; IL23R GENE; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; OCTN1 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84872126330     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30195-4     Document Type: Article

References (43)

1. Martins NB, Peppercorn MA. Inflammatory bowel disease. Am J Manag Care. 2004;10(8):544-552.
2. Lakatos L, Mester G, Erdelyi Z, et al. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol. 2004;10(3):404-409.
3. Lidar M, Langevitz P, Barzilai O, et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci. 2009;1173:640-648.
4. Newman B, Siminovitch K. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics. Clin Invest Med. 2003;26(6):303-314.
5. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31(1):1-20.
6. Mendeloff AI, Monk M, Siegel CI, et al. Some epidemiological features of ulcerative colitis and regional enteritis. A preliminary report. Gastroenterology. 1966;51(5):748-756.
7. Cross RK, Jung C, Wasan S, et al. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12(3):192-198.
8. Jackson JF III, Dhere T, Repaka A, et al. Crohn's disease in an African-American population. Am J Med Sci. 2008;336(5):389-392.
9. Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101(5):1012-1023.
10. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34(12):1841-1854.
11. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603.
12. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603- 606.
13. Dassopoulos T, Nguyen GC, Talor MV, et al. NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans. Am J Gastroenterol. 2010;105(2):378-386.
14. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314(5804):1461-1463.
15. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168(11):5699-5708.
16. Mudter J, Weigmann B, Bartsch B, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol. 2005;100(1):64-72.
17. Taylor KD, Targan SR, Mei L, et al. IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm Bowel Dis. 2008;14(9):1185-1191.
18. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39(2):207-211.
19. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39(5):596-604.
20. Libioulle C, Louis E, Hansoul S, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007;3(4):e58.
21. Noble CL, Nimmo ER, Drummond H, et al. The contribution of OCTN1/2 Crohn's Disease in Caucasians and African Americans variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology. 2005;129(6):1854-64.
22. Crawford NP, Eichenberger MR, Colliver DW, et al. Evaluation of SLC11A1 as an inflammatory bowel disease candidate gene. BMC Med Genet. 2005;6:10.
23. Mahid SS, Colliver DW, Crawford NP, et al. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. BMC Med Genet. 2007;8:28.
24. Centers for Disease Control and Prevention BRFSSSDB. Percent of Adults who Smoke by Sex. 2008.
25. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6(1):8-15.
26. Armuzzi A, Ahmad T, Ling KL, et al. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut. 2003;52(8):1133-1139.
27. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004;36(5):471-475.
28. Ogunbi SO, Ransom JA, Sullivan K, et al. Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998;133(1):103-107.
29. Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101(5):1012-1023.
30. Mahid SS, Mulhall AM, Gholson RD, et al. Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis. 2008;14(7):960-967.
31. Agrez MV, Valente RM, Pierce W, et al. Surgical history of Crohn's disease in a well-defined population. Mayo Clin Proc. 1982;57(12):747-752.
32. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991;100(1):143-149.
33. Simsek H, Schuman BM. Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery. J Clin Gastroenterol. 1989;11(3):294-298.
34. Livingston EH, Cao J. Procedure volume as a predictor of surgical outcomes. JAMA. 2010;304(1):95-97.
35. Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100(10):2254-2261.
36. Cross RK, Jung C, Wasan S, et al. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12(3):192-198.
37. Deveaux PG, Kimberling J, Galandiuk S. Crohn's disease: presentation and severity compared between black patients and white patients. Dis Colon Rectum. 2005;48(7):1404-1409.
38. Goldman CD, Kodner IJ, Fry RD, et al. Clinical and operative experience with non-Caucasian patients with Crohn's disease. Dis Colon Rectum. 1986;29(5):317-321.
39. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49(6):777-782.
40. Samuels AD, Weese JL, Berman PM, et al. An epidemiologic and demographic study of inflammatory bowel disease in black patients. Am J Dig Dis. 1974;19(2):156-160.
41. Rioux JD, Silverberg MS, Daly MJ, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 2000;66(6):1863-1870.
42. Bonen DK, Nicolae DL, Moran T, et al. Racial differences in NOD2 variation: characterization of NOD2 in African-Americans with Crohn's Disease (abstr). Gastroenterology. 2002;122A-129A.
43. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123(1):86-91.